NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
13F holders, Q1 2024
Institutional positions in NewAmsterdam Pharma Co N.V. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 76
- +44 vs. Q4 2023
- Shares held
- 72.2M
- +10.3M (+16.6%) vs. Q4 2023
- Total value
- $1.71B
- +$1.01B (+146.8%) vs. Q4 2023
- New holders
- 46
- 13 more added
- Sold out
- 2
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NAMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 194 | $4.13B |
| Q1 2026 | 171 | $3.96B |
| Q4 2025 | 187 | $4.19B |
| Q3 2025 | 137 | $3.43B |
| Q2 2025 | 131 | $2.11B |
| Q1 2025 | 126 | $2.28B |
| Q4 2024 | 131 | $2.53B |
| Q3 2024 | 100 | $1.28B |
| Q2 2024 | 90 | $1.38B |
| Q1 2024 | 76 | $1.71B |
| Q4 2023 | 32 | $691.4M |
| Q3 2023 | 35 | $464.1M |
| Q2 2023 | 29 | $580.6M |
| Q1 2023 | 19 | $444.9M |
| Q4 2022 | 14 | $362.2M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding NewAmsterdam Pharma Co N.V.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DuPont Capital Management Corp | 1 | $24 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 5 | $118 | 0.00% | +5 | New |
| Barclays PLC | 94 | $2.22K | 0.00% | −419−81.7% | Reduced |
| Stone House Investment Management, LLC | 325 | $7.69K | 0.00% | +325 | New |
| Wells Fargo & Company | 500 | $11.8K | 0.00% | +200+66.7% | Added |
| PSI Advisors, LLC | 500 | $11.8K | 0.00% | +500 | New |
| Signaturefd, LLC | 647 | $15.3K | 0.00% | +647 | New |
| Bradley & Co. Private Wealth Management, LLC | 729 | $17.2K | 0.01% | +729 | New |
| Canton Hathaway, LLC | 1,000 | $24.0K | 0.01% | +1,000 | New |
| Bank of America Corp | 2,000 | $47.3K | 0.00% | +2,000 | New |
| Royal Bank of Canada | 3,450 | $82.0K | 0.00% | −7,425−68.3% | Reduced |
| JPMorgan Chase & Co | 4,319 | $102.1K | 0.00% | +4,319 | New |
| US Bancorp | 6,461 | $152.8K | 0.00% | +6,461 | New |
| CIBC Private Wealth Group, LLC | 7,640 | $163.3K | 0.00% | +7,640 | New |
| Wolverine Asset Management LLC | 7,130 | $168.6K | 0.00% | −1,564−18.0% | Reduced |
| Envestnet Asset Management Inc | 9,039 | $213.8K | 0.00% | +9,039 | New |
| Two Sigma Advisers, LP | 9,100 | $215.2K | 0.00% | +9,100 | New |
| BlackRock Inc. | 11,220 | $265.4K | 0.00% | −11,721−51.1% | Reduced |
| Venture Visionary Partners LLC | 11,700 | $276.7K | 0.01% | +1,700+17.0% | Added |
| Glenmede Trust Co NA | 12,665 | $299.5K | 0.00% | +12,665 | New |
| Cinctive Capital Management LP | 15,041 | $355.7K | 0.02% | +15,041 | New |
| M&T Bank Corp | 15,738 | $372.1K | 0.00% | +15,738 | New |
| SEI Investments Co | 16,474 | $389.6K | 0.00% | +16,474 | New |
| HealthInvest Partners AB | 22,394 | $529.6K | 0.32% | +22,394 | New |
| Cubist Systematic Strategies, LLC | 22,993 | $543.8K | 0.01% | +22,993 | New |
| Yarbrough Capital, LLC | 23,960 | $566.7K | 0.02% | +23,960 | New |
| Gilder Gagnon Howe & Co LLC | 24,466 | $578.6K | 0.01% | +24,466 | New |
| Y-Intercept (Hong Kong) Ltd | 26,208 | $619.8K | 0.05% | +26,208 | New |
| Lighthouse Investment Partners, LLC | 29,357 | $694.3K | 0.04% | +29,357 | New |
| Alyeska Investment Group, L.P. | 35,641 | $842.9K | 0.01% | +35,641 | New |
| UBS Group AG | 48,279 | $1.14M | 0.00% | +47,479+5,934.9% | Added |
| Two Sigma Investments, LP | 51,675 | $1.22M | 0.00% | +51,675 | New |
| Geode Capital Management, LLC | 52,185 | $1.23M | 0.00% | +4,861+10.3% | Added |
| Artia Global Partners LP | 54,285 | $1.28M | 0.31% | +54,285 | New |
| J. Goldman & Co LP | 78,834 | $1.86M | 0.08% | +78,834 | New |
| StemPoint Capital LP | 80,334 | $1.90M | 0.51% | +80,334 | New |
| Baker Bros. Advisors LP | 96,827 | $2.29M | 0.03% | +96,827 | New |
| Silverarc Capital Management, LLC | 99,612 | $2.36M | 0.66% | +99,612 | New |
| Moody Aldrich Partners LLC | 111,267 | $2.63M | 0.45% | +111,267 | New |
| Marshall Wace, LLP | 115,380 | $2.73M | 0.00% | +81,439+239.9% | Added |
| Schonfeld Strategic Advisors LLC | 122,000 | $2.89M | 0.02% | +55,100+82.4% | Added |
| Monashee Investment Management LLC | 170,000 | $4.02M | 0.48% | +170,000 | New |
| Perceptive Advisors LLC | 175,000 | $4.14M | 0.07% | +175,000 | New |
| Nantahala Capital Management, LLC | 175,000 | $4.14M | 0.41% | +175,000 | New |
| Morgan Stanley | 177,588 | $4.20M | 0.00% | +149,050+522.3% | Added |
| Parkman Healthcare Partners LLC | 200,311 | $4.74M | 0.58% | −100,439−33.4% | Reduced |
| Wellington Management Group LLP | 218,082 | $5.16M | 0.00% | +218,082 | New |
| TimesSquare Capital Management, LLC | 228,616 | $5.41M | 0.08% | +228,616 | New |
| FMR LLC | 243,700 | $5.76M | 0.00% | +243,700 | New |
| Ensign Peak Advisors, Inc | 246,106 | $5.82M | 0.01% | +54,150+28.2% | Added |
| AXA S.A. | 249,251 | $5.89M | 0.02% | −27,077−9.8% | Reduced |
| Affinity Asset Advisors, LLC | 286,200 | $6.77M | 1.10% | +161,200+129.0% | Added |
| ArrowMark Colorado Holdings LLC | 296,807 | $7.02M | 0.08% | +296,807 | New |
| Opaleye Management Inc. | 315,388 | $7.46M | 1.63% | +50,000+18.8% | Added |
| Eversept Partners, LP | 353,965 | $8.37M | 0.63% | −20,439−5.5% | Reduced |
| Octagon Capital Advisors LP | 408,000 | $9.65M | 1.17% | +408,000 | New |
| Citadel Advisors LLC | 454,334 | $10.7M | 0.01% | +433,288+2,058.8% | Added |
| Avidity Partners Management LP | 475,000 | $11.2M | 0.40% | +475,000 | New |
| Janus Henderson Group PLC | 636,231 | $15.0M | 0.01% | +636,231 | New |
| Pictet Asset Management Holding SA | 649,736 | $15.4M | 0.02% | +649,736 | New |
| Deerfield Management Company, L.P. (Series C) | 667,000 | $15.8M | 0.27% | +667,000 | New |
| Artal Group S.A. | 800,000 | $18.9M | 0.49% | +800,000 | New |
| Jennison Associates LLC | 930,851 | $22.0M | 0.01% | +930,851 | New |
| GMT Capital Corp | 943,136 | $22.3M | 0.88% | −440,664−31.8% | Reduced |
| Millennium Management LLC | 947,527 | $22.4M | 0.02% | −378,576−28.5% | Reduced |
| Polar Capital Holdings Plc | 1,252,586 | $29.6M | 0.18% | +1,252,586 | New |
| Goldman Sachs Group Inc | 1,283,455 | $30.4M | 0.01% | −100,866−7.3% | Reduced |
| Cormorant Asset Management, LP | 1,500,000 | $35.5M | 1.56% | +1,500,000 | New |
| BVF Inc | 1,521,948 | $36.0M | 0.99% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,824,601 | $43.2M | 0.08% | +524,601+40.4% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 2,869,565 | $67.9M | 15.11% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,864,000 | $186.0M | 2.37% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 8,024,565 | $189.8M | 0.71% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 10,473,913 | $247.7M | 19.91% | 00.0% | Unchanged |
| FCPM III Services B.V. | 11,831,461 | $279.8M | 39.56% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 12,226,943 | $289.2M | 12.20% | +95,238+0.8% | Added |
| Cutler Group LP | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Atticus Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |